Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy

Michelle E Keyel,1,2 C Patrick Reynolds1–4 1Cancer Center, 2Department of Pediatrics, 3Department of Internal Medicine, 4Department of Cell Biology & Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA Abstract: Neuroblastoma (N...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Keyel ME, Reynolds CP
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
GD2
Acceso en línea:https://doaj.org/article/54f44a9d7f4444ea894f7bcee0cad1d9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!